Condition: Persistent Atrial Fibrillation · Sponsor: Boston Scientific Corporation
The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.
This description comes directly from the study's public registry record.
Kristin Mathson · 612.417.9538 · Kristin.Mathson@bsci.com
Kaitlyn Aldrich · +16515824790 · kaitlyn.aldrich@bsci.com
Always discuss trial participation with your own doctor first.
| Mobile Infirmary Medical Center | Mobile, Alabama, United States | Recruiting |
| Arrhythmia Research Group-Research Facility | Jonesboro, Arkansas, United States | Recruiting |
| University of Southern California Hospital | Los Angeles, California, United States | Recruiting |
| St. John's Regional Medical Center | Oxnard, California, United States | Recruiting |
| Stanford University Medical Center | Stanford, California, United States | Recruiting |
| South Denver Cardiology Associates, PC | Littleton, Colorado, United States | Recruiting |
| HCA Florida Mercy Hospital | Miami, Florida, United States | Recruiting |
| Naples Comprehensive Health | Naples, Florida, United States | Recruiting |
| AdventHealth Orlando-Hospital | Orlando, Florida, United States | Recruiting |
| Tampa General Hospital | Tampa, Florida, United States | Recruiting |
| AdventHealth Tampa-Hospital | Tampa, Florida, United States | Recruiting |
| Emory University Hospital | Atlanta, Georgia, United States | Recruiting |
+ 29 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06735534